<DOC>
	<DOCNO>NCT02829788</DOCNO>
	<brief_summary>The peritoneum second common site recurrence patient colorectal cancer . Cytoreductive surgery hyperthermic intraperitoneal chemotherapy improve prognosis patient incorporate surgical removal visible disease follow chemical destruction microscopic disease chemoperfusion . The validated predictor outcome preoperative tumor burden measure term peritoneal carcinomatosis index ( PCI ) completeness cytoreduction ( CC score ) . Diagnostic laparoscopy prior resection widely use hepatopancreaticobiliary colorectal cancer show effective exclude unnecessary laparotomy associate high morbidity .</brief_summary>
	<brief_title>Study Comparing Role Laparoscopy Surgical Staging Peritoneal Carcinomatosis Laparotomic Approach</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<criteria>Patients Colorectal cancer resect minimal synchronous peritoneal carcinomatosis , ovarian metastasis , tumour rupture abdominal cavity . Patients receive six month systemic chemotherapy ( currently Folfox4 regimen could modify standard modify )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Digestive peritoneal carcinomatosis</keyword>
	<keyword>laparoscopy</keyword>
	<keyword>laparotomy</keyword>
	<keyword>peritoneal cancer index ( PCI )</keyword>
	<keyword>stag</keyword>
</DOC>